Department of Internal Medicine, Konkuk University School of Medicine, 4-12 Hwayang-dong, Gwangjin-gu, Seoul 143-729, Korea.
Dig Dis Sci. 2012 Mar;57(3):753-63. doi: 10.1007/s10620-011-1926-1. Epub 2011 Oct 8.
A higher circulating vitamin D level is inversely associated with the risk of colorectal cancer, but the association with adenoma risk is less clear.
We examined the association between the circulating 25-hydroxyvitamin D(3) [25(OH)D(3)] concentration and colorectal adenoma in asymptomatic average-risk participants undergoing initial screening colonoscopy.
The study subjects were comprised of 143 cases of colorectal adenomas and 143 age- and gender-matched controls with normal colonoscopy among the 586 asymptomatic average-risk subjects (median age, 58 years; range, 50-73 years) who underwent first screening colonoscopy and measurement of the serum 25(OH)D(3) between December 2009 and April 2010, consistent with winter months of the region.
The mean concentration of serum 25(OH)D(3) in the adenoma and control groups was 20.0 ± 11.0 ng/ml and 25.0 ± 20.0 ng/ml, respectively (P = 0.009). Using multivariate analysis, higher levels of 25(OH)D(3) were associated with a statistically significant decreased risk of colorectal adenoma after multivariable adjustment (highest vs. lowest quartile OR 0.38, 95% CI 0.18-0.80, P (trend) = 0.012). The inverse association of circulating 25(OH)D(3) with colorectal adenoma was stronger among the patients with proximal adenoma than that among the patients without proximal adenoma (highest vs. lowest quartile OR 0.29, 95% CI 0.13-0.66, P (trend) = 0.001).
The present study suggests that high levels of circulating vitamin D are associated with a decreased risk of colorectal adenoma, and especially adenoma located in the proximal colon.
循环中维生素 D 水平越高,与结直肠癌的风险呈反比,但与腺瘤风险的关系尚不清楚。
我们研究了无症状低危人群初次筛查性结肠镜检查中循环 25-羟维生素 D(3) [25(OH)D(3)] 浓度与结直肠腺瘤之间的关系。
研究对象为在 2009 年 12 月至 2010 年 4 月间进行首次筛查性结肠镜检查和血清 25(OH)D(3) 检测的 586 例无症状低危人群(中位年龄 58 岁,范围 50-73 岁)中,143 例结直肠腺瘤患者和 143 例结肠镜正常的年龄和性别匹配对照者。血清 25(OH)D(3) 浓度的测量与该地区冬季时间一致。
腺瘤组和对照组血清 25(OH)D(3) 的平均浓度分别为 20.0 ± 11.0 ng/ml 和 25.0 ± 20.0 ng/ml(P = 0.009)。多变量分析显示,校正多变量后,25(OH)D(3) 水平较高与结直肠腺瘤风险显著降低相关(最高四分位比最低四分位 OR 0.38,95% CI 0.18-0.80,P (趋势) = 0.012)。25(OH)D(3) 与结直肠腺瘤之间的负相关在近端腺瘤患者中比无近端腺瘤患者中更强(最高四分位比最低四分位 OR 0.29,95% CI 0.13-0.66,P (趋势) = 0.001)。
本研究表明,循环中维生素 D 水平较高与结直肠腺瘤风险降低相关,尤其是位于近端结肠的腺瘤。